gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · CLPTHealthcareSurgical Instruments

ClearPoint Neuro, Inc. Common Stock (CLPT)

$10.16+4.63%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$10.16▼ 42.01% in range
Nov 4, 2025Low $8.66 · High $19.43Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

ClearPoint Neuro closed at $10.16 on Nov 4, up 4.63%, 47.7% below its 52-week closing high. Volume of 674.5K shares was 1.00× its 20-day average (close to normal).

Split-adjusted performance: -7.7% over one month, -11.4% over six months, -46.5% over one year.

In the quarter ended Sep 30, 2026, revenue was $12.07M, up 36.3% from a year earlier, with a net margin of -61.8%.

Short interest was 4.6M shares at the Oct 15 settlement, down 2.8% from the prior report (16.3% of float, 6.6 days to cover).

Market cap$325.7M32.1M shares
Revenue · quarter$12.1M+36.3% YoY
Diluted EPS$-0.24—
P/E · TTM—P/S 7.2×
Net margin-61.8%Gross 58.5%
Dividend yieldNone
52-week range8.66 – 19.43−47.7% from high
Volume674.5K1.00× 20-day avg
Volatility · 60d82.4%Annualised
Short % of float16.3%6.6 days to cover
Net cash-$4.7MCash $46.2M
Next earnings—Not scheduled
Split-adjusted performance
1W −3.8%1M −7.7%3M −24.1%6M −11.4%YTD −25.7%1Y −46.5%3Y +87.5%5Y −38.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum46
Revenue growth91
Net margin28
Value (low P/E)—
Size51

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short4.6M−2.8% vs prior
Days to cover6.6Settled Oct 15
% of float16.3%
Short vol. 10d48.6%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
CLPTClearPoint Neuro$10.16+4.63%−11.4%+36.3%−61.8%—$325.7M
OBIOOrchestra BioMed Holdings$6.00+7.91%+46.0%−89.5%−27362.5%—$360.6MCompare
TMCITreace Medical Concepts$4.50+5.14%+133.2%−4.2%−35.0%—$292.7MCompare
EMBCEmbecta$6.52+7.24%+83.1%−8.1%7.8%4.2$369.4MCompare
MOBIMobia Medical$11.24+12.74%——−155.8%—$374.2MCompare
ANIKAnika Therapeutics$20.40+4.88%+34.9%+15.6%10.1%—$273.0MCompare
OFIXOrthofix Medical Inc. Common Stock (DE)$9.72+10.96%−20.3%+3.8%−7.5%—$395.9MCompare
INFUInfuSystem Holdings$13.15+2.73%+29.7%+2.6%8.7%30.7$261.9MCompare
PROFProfound Medical$7.16+2.43%−0.8%+12.3%−384.2%—$261.6MCompare

News about ClearPoint Neuro

All news →
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research · Oct 28, 2026▼ NegativeINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPTGlobeNewswire Inc. · Oct 13, 2026▼ Negative

Quick answers

What does ClearPoint Neuro do?
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space.
What is CLPT's market cap?
$325.67M, based on the Nov 4 close of $10.16.
Does ClearPoint Neuro pay a dividend?
No regular cash dividend has been paid in the last year.
How much of CLPT is sold short?
4.6M shares, 16.3% of float, as of Oct 15, 2026.
What sector is CLPT in?
Healthcare, in the Surgical Instruments industry.

About ClearPoint Neuro

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.

HQ: Solana Beach, CA172 employeesListed May 18, 2012clearpointneuro.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology